An Open-Label Extension Study to Evaluate the Safety and Tolerability of RWJ 333369 as Adjunctive Therapy in Patients 16 Years and Older With Partial Onset Seizures.

NCT00991757 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

991

Enrollment

INDUSTRY

Sponsor class

Conditions

Epilepsy
Complex Partial Seizures
Epilepsy, Complex Partial
Epilepsies, Partial

Interventions

DRUG: carisbamate

Sponsor

SK Life Science, Inc.